Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
ppm decrease » _ decrease (Expand Search), nn decrease (Expand Search), pa decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
ppm decrease » _ decrease (Expand Search), nn decrease (Expand Search), pa decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
14861
-
14862
-
14863
-
14864
Image1_Restricting Glutamine Uptake Enhances NSCLC Sensitivity to Third-Generation EGFR-TKI Almonertinib.TIF
Published 2021“…The combination of SLC1A5 inhibitor V9302 and Almonertinib had a synergistic inhibitory effect on the proliferation of NSCLC. …”
-
14865
Patients’ clinicopathological characteristics.
Published 2025“…The mean total operation time was 272.50±66.74 minutes while mean oncologic mastectomy was 155.61±43.21 minutes. …”
-
14866
Oncologic results.
Published 2025“…The mean total operation time was 272.50±66.74 minutes while mean oncologic mastectomy was 155.61±43.21 minutes. …”
-
14867
Perioperative parameters.
Published 2025“…The mean total operation time was 272.50±66.74 minutes while mean oncologic mastectomy was 155.61±43.21 minutes. …”
-
14868
Perioperative complications.
Published 2025“…The mean total operation time was 272.50±66.74 minutes while mean oncologic mastectomy was 155.61±43.21 minutes. …”
-
14869
-
14870
-
14871
-
14872
-
14873
-
14874
-
14875
IL-15 decreases PC3 and 22RV1 cell invasion <i>in vitro</i>.
Published 2017“…PC3 (Top) 22RV1 (Bottom) (B) Statistical analysis shows that IL-15 treatment causes a significant decrease in cell invasion. PC3 (Top) 22RV1 (Bottom). …”
-
14876
-
14877
-
14878
-
14879
-
14880